Modeling of Urinary Microbiota Associated With Cystitis.

16S rRNA sequencing antibiotics microbial interaction modeling microbiome therapy duration urinary tract infection

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 18 12 2020
accepted: 10 02 2021
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 6 7 2021
Statut: epublish

Résumé

A decade ago, when the Human Microbiome Project was starting, urinary tract (UT) was not included because the bladder and urine were considered to be sterile. Today, we are presented with evidence that healthy UT possesses native microbiota and any major event disrupting its "equilibrium" can impact the host also. This dysbiosis often leads to cystitis symptoms, which is the most frequent lower UT complaint, especially among women. Cystitis is one of the most common causes of antimicrobial drugs prescriptions in primary and secondary care and an important contributor to the problem of antimicrobial resistance. Despite this fact, we still have trouble distinguishing whether the primary cause of majority of cystitis cases is a single pathogen overgrowth, or a systemic disorder affecting entire UT microbiota. There are relatively few studies monitoring changes and dynamics of UT microbiota in cystitis patients, making this field of research still an unknown. In this study variations to the UT microbiota of cystitis patients were identified and microbial dynamics has been modeled. The microbial genetic profile of urine samples from 28 patients was analyzed by 16S rDNA Illumina sequencing and bioinformatics analysis. One patient with bacterial cystitis symptoms was prescribed therapy based on national guideline recommendations on antibacterial treatment of urinary tract infections (UTI) and UT microbiota change was monitored by 16S rDNA sequencing on 24 h basis during the entire therapy duration. The results of sequencing implied that a particular class of bacteria is associated with majority of cystitis cases in this study. The contributing role of this class of bacteria -

Identifiants

pubmed: 33796485
doi: 10.3389/fcimb.2021.643638
pmc: PMC8008076
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

643638

Informations de copyright

Copyright © 2021 Ceprnja, Oros, Melvan, Svetlicic, Skrlin, Barisic, Starcevic, Zucko and Starcevic.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Curr Opin Urol. 2017 May;27(3):282-286
pubmed: 28234750
J Clin Microbiol. 2014 Jan;52(1):139-46
pubmed: 24172157
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
J Clin Microbiol. 2012 Apr;50(4):1376-83
pubmed: 22278835
Curr Opin Obstet Gynecol. 2016 Oct;28(5):407-12
pubmed: 27379439
Microbiome. 2019 Aug 22;7(1):118
pubmed: 31439018
Lijec Vjesn. 2009 May-Jun;131(5-6):105-18
pubmed: 19642528
J Travel Med. 2019 Dec 23;26(8):
pubmed: 31115466
Trends Biotechnol. 2020 May;38(5):497-518
pubmed: 31980301
Microbiome. 2017 Aug 14;5(1):99
pubmed: 28807017
PLoS One. 2010 Nov 24;5(11):e14116
pubmed: 21124791
BMC Microbiol. 2012 Sep 13;12:205
pubmed: 22974186
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Sci Rep. 2019 Jul 5;9(1):9788
pubmed: 31278344
Front Cell Infect Microbiol. 2013 Aug 15;3:41
pubmed: 23967406
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
J Transl Med. 2012 Aug 28;10:174
pubmed: 22929533
Curr Bladder Dysfunct Rep. 2016 Mar;11(1):18-24
pubmed: 27182288
Bioinform Biol Insights. 2015 May 05;9:75-88
pubmed: 25983555
ISME J. 2012 Mar;6(3):610-8
pubmed: 22134646
mBio. 2020 Apr 28;11(2):
pubmed: 32345639
J Clin Microbiol. 2014 Mar;52(3):871-6
pubmed: 24371246
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004682
pubmed: 15846726
West J Med. 2002 Jan;176(1):51-5
pubmed: 11788540
Mol Syst Biol. 2018 Jun 21;14(6):e8157
pubmed: 29930200
Nat Rev Urol. 2015 Feb;12(2):81-90
pubmed: 25600098
Nat Rev Urol. 2018 Dec;15(12):735-749
pubmed: 30315209
BMC Microbiol. 2019 Jan 9;19(1):9
pubmed: 30626324
Clin Proteomics. 2020 Jun 23;17:25
pubmed: 32581661
Am J Obstet Gynecol. 2015 Nov;213(5):644-9
pubmed: 26003055
PLoS One. 2014 Apr 08;9(4):e93827
pubmed: 24714158
Sci Rep. 2018 Mar 12;8(1):4333
pubmed: 29531289
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
J Antimicrob Chemother. 2015;70(6):1604-7
pubmed: 25673635

Auteurs

Marina Ceprnja (M)

Biochemical Laboratory, Special Hospital Agram, Polyclinic Zagreb, Zagreb, Croatia.
Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, Zagreb University, Zagreb, Croatia.

Damir Oros (D)

Laboratory for Bioinformatics, Faculty of Food Technology and Biotechnology, Zagreb University, Zagreb, Croatia.

Ena Melvan (E)

Laboratory for Bioinformatics, Faculty of Food Technology and Biotechnology, Zagreb University, Zagreb, Croatia.
Department of Biological Science, Faculty of Science, Macquarie University, Sydney, NSW, Australia.

Ema Svetlicic (E)

Laboratory for Bioinformatics, Faculty of Food Technology and Biotechnology, Zagreb University, Zagreb, Croatia.

Jasenka Skrlin (J)

Department for Clinical Microbiology and Hospital Infection, University Hospital Dubrava, Zagreb, Croatia.

Karmela Barisic (K)

Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, Zagreb University, Zagreb, Croatia.

Lucija Starcevic (L)

Laboratory for Bioinformatics, Faculty of Food Technology and Biotechnology, Zagreb University, Zagreb, Croatia.

Jurica Zucko (J)

Laboratory for Bioinformatics, Faculty of Food Technology and Biotechnology, Zagreb University, Zagreb, Croatia.

Antonio Starcevic (A)

Laboratory for Bioinformatics, Faculty of Food Technology and Biotechnology, Zagreb University, Zagreb, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH